Explore more publications!
Healthcare Brief Comoros
Got News to Share?

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 19, 2026

Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
23 minutes ago

Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships

Indeterminate GlobeNewswire
Reacta Healthcare Appoints Richard Nagle as Chair of Board of Directors
an hour ago

Reacta Healthcare Appoints Richard Nagle as Chair of Board of Directors

Indeterminate GlobeNewswire
Philips publishes its Annual Report 2025
an hour ago

Philips publishes its Annual Report 2025

Indeterminate GlobeNewswire
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
an hour ago

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants
3 hours ago

Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants

Indeterminate GlobeNewswire
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
4 hours ago

Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook

Indeterminate GlobeNewswire
Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2025 et fournit ses prévisions pour l’exercice 2026
4 hours ago

Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2025 et fournit ses prévisions pour l’exercice 2026

Indeterminate GlobeNewswire
BioVersys and Partners’ Phase 2a Tuberculosis Trial Results Published in New England Journal of Medicine
4 hours ago

BioVersys and Partners’ Phase 2a Tuberculosis Trial Results Published in New England Journal of Medicine

Indeterminate GlobeNewswire
Valneva meldet vorläufige ungeprüfte Umsätze und liquide Mittel für 2025; gibt einen Ausblick für 2026
4 hours ago

Valneva meldet vorläufige ungeprüfte Umsätze und liquide Mittel für 2025; gibt einen Ausblick für 2026

Indeterminate GlobeNewswire
Zealand Pharma Announces Financial Results for the Full Year 2025
4 hours ago

Zealand Pharma Announces Financial Results for the Full Year 2025

Indeterminate GlobeNewswire
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
4 hours ago

argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026

Indeterminate GlobeNewswire
Rapid Nutrition PLC – Strategic Outlook and Near-Term Execution Update
6 hours ago

Rapid Nutrition PLC – Strategic Outlook and Near-Term Execution Update

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions